Chemoinformaics analysis of 3",4"- (O-diacetylafzelin
| Molecular Weight | 516.455 | nRot | 5 |
| Heavy Atom Molecular Weight | 492.263 | nRig | 26 |
| Exact Molecular Weight | 516.127 | nRing | 4 |
| Solubility: LogS | -4.362 | nHRing | 2 |
| Solubility: LogP | 2.436 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 67.377 |
| nHD | 4 | BPOL | 35.361 |
| QED | 0.362 |
| Synth | 4.068 |
| Natural Product Likeliness | 1.962 |
| NR-PPAR-gamma | 0.944 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.518 |
| Pgp-sub | 0.036 |
| HIA | 0.277 |
| CACO-2 | -5.688 |
| MDCK | 0.0000384 |
| BBB | 0.016 |
| PPB | 0.863038 |
| VDSS | 0.79 |
| FU | 0.219582 |
| CYP1A2-inh | 0.145 |
| CYP1A2-sub | 0.059 |
| CYP2c19-inh | 0.057 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.152 |
| CYP2c9-sub | 0.688 |
| CYP2d6-inh | 0.922 |
| CYP2d6-sub | 0.149 |
| CYP3a4-inh | 0.646 |
| CYP3a4-sub | 0.081 |
| CL | 1.505 |
| T12 | 0.867 |
| hERG | 0.015 |
| Ames | 0.572 |
| ROA | 0.098 |
| SkinSen | 0.05 |
| Carcinogencity | 0.14 |
| EI | 0.051 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.921 |
| Antiviral | Yes |
| Prediction | 0.929852 |